Intelligent Ultrasound Group PLC AGM Statement (6895P)

TIDMIUG

RNS Number : 6895P

Intelligent Ultrasound Group PLC

22 June 2022

Intelligent Ultrasound Group plc

("Intelligent Ultrasound" or the "Group" or the "Company")

AGM statement

Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic' ultrasound company, specialising in artificial intelligence (AI) software and simulation, announces that at the AGM due to be held today at 11:00am at the offices of Memery Crystal, 165 Fleet Street, London EC4A 2DY, Non-Executive Chairman Riccardo Pigliucci will make the following statement:

" As noted at the publication of our full year results, we have had a strong start to 2022 and we continue to be confident in the upgraded market expectations for the full year 2022 revenue. We remain excited about the potential of our 'Classroom to Clinic' business."

The full voting results will be available on the website later today.

For further information, please contact:

 
Intelligent Ultrasound Group                                          www. intelligentultrasound.com 
 plc 
Stuart Gall, CEO                                                            Tel: [phone] 
 
Helen Jones, CFO 
 
 
Cenkos Securities - Nominated Advisor 
 and Broker 
Giles Balleny/Max Gould (Corporate                                          Tel: [phone] 
 Finance) 
Michael Johnson/Julian Morse 
 (Sales) 
 
 
 
Walbrook PR                         Tel: [phone] or [e-mail] 
Anna Dunphy/Paul McManus                                         Mob: [phone] / Mob: +44 
                                                                                     (0)7980 541 893 
 
 
 

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to clinic' ultrasound companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market ('classroom') and artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market ('clinic'). Based in Cardiff in the UK and Atlanta in the US, the Group has two revenue streams:

Simulation

Real-time hi-fidelity ultrasound education and training through simulation. Our main products are the ScanTrainer obstetrics and gynaecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid-19 module and the new BabyWorks Neonate and Paediatric training simulator. To date over 1,350 simulators have been sold to over 650 medical institutions around the world.

Clinical AI software

Deep learning-based algorithms to make ultrasound machines smarter and more accessible using our proprietary ScanNav ultrasound image analysis technology. Current products on the market utilising this technology are GE Healthcare's SonoLyst software that is incorporated in their Voluson SWIFT ultrasound machine; ScanNav Anatomy PNB that simplifies ultrasound-guided needling by providing the user with real-time AI-based anatomy highlighting for a range of medical procedures; and NeedleTrainer that teaches real-time ultrasound-guided needling and incorporates ScanNav Anatomy PNB.

www.intelligentultrasound.com

NOTE: ScanNav Anatomy PNB is CE approved, but not yet available for sale in the US or any other territory requiring government approval for this type of product.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

AGMSEUFIFEESEFM

(END) Dow Jones Newswires

June 22, 2022 02:00 ET (06:00 GMT)